⌘K

Login Start Free

Home/Filings/4/0001493152-24-047261

4//SEC Filing

Yu John S 4

Accession 0001493152-24-047261

CIK 0001962011other

View on SEC.gov Company Profile

Filed

Nov 20, 7:00 PM ET

Accepted

Nov 21, 9:53 PM ET

Size

4.5 KB

Accession

0001493152-24-047261

Insider Transaction Report

Form 4

Period: 2024-11-20

Kairos Pharma, LTD.KAPA

DirectorCEO and Chairman10% Owner

Transactions

Purchase
COMMON STOCK
2024-11-20$1.44/sh+4,000$5,760→ 5,341,837 total

Documents

1 file

4
ownership.xmlPrimary

Issuer

Kairos Pharma, LTD.

CIK 0001962011

Entity typeother

Related Parties

1

filerCIK 0001550545

Filing Metadata

Form type: 4
Filed: Nov 20, 7:00 PM ET
Accepted: Nov 21, 9:53 PM ET
Size: 4.5 KB

View on SEC.gov